LubeluzoleAlternative Names: JK 8792; Prosynap; R 87926
Latest Information Update: 03 Apr 2001
At a glance
- Originator Janssen L.P.
- Developer Janssen Pharmaceutical KK
- Class Anti-ischaemics; Neuroprotectants; Piperidines; Small molecules; Thiazoles
- Mechanism of Action Glutamate receptor antagonists; Nitric oxide inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Stroke